Bypass vs endovascular treatment for occluded femoro-popliteal stents in patients with critical limb-threatening ischemia.

Femoro-popliteal artery Multicenter Peripheral arterial disease Stent Thrombosis

Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 11 05 2023
revised: 17 07 2023
accepted: 25 07 2023
pubmed: 3 8 2023
medline: 3 8 2023
entrez: 2 8 2023
Statut: ppublish

Résumé

The aim of the study was to compare the early and medium-term outcomes of bypass vs endovascular treatment of occluded femoro-popliteal stents in patients with chronic limb-threatening ischemia (the OUT-STEPP multicentric registry). Between January 2016 and December 2021, 317 patients in 14 centers underwent treatment for a symptomatic occlusion of femoro-popliteal stent/stents. One hundred sixty-one patients were included into the present study: 46 (28.6%) underwent open bypass surgery (Group OPEN), and 115 (71.4%) underwent endovascular revascularization (Group ENDO). Early (30 days) results were assessed and compared between the two groups. Estimated 5-year outcomes were evaluated and compared with the log rank test. At 30 days, no differences were found in terms of major adverse cardiovascular events, acute kidney injury, reinterventions, major amputation, and all-cause mortality between the two groups. The need for blood transfusions was higher for patients in Group OPEN (17; 36.9% vs 13; 11.3%; P < .001). The mean length of intensive care unit stay and the mean hospital stay were higher for patients in Group OPEN ([0.3 ± 0.9 vs 0 days; P < .001] and [9.7 ± 5.8 vs 3.3 ± 1.4 days; P < .001], respectively). The overall median duration of follow-up was 33.1 months (interquartile range, 14-49.5 months). At 5 years, there were no differences between the two groups in terms of survival (68.7% Group OPEN vs 68.8% Group ENDO; P = .27; log-rank, 1.21), primary patency (56.3% Group OPEN vs 67.8% Group ENDO; P = .39; log-rank, 0.75), secondary patency (59.1% Group OPEN vs 77.8% Group ENDO; P = .24; log-rank, 1.40), absence of target lesion restenosis (56.8% Group OPEN vs 62.7% Group ENDO; P = .42; log-rank, 0.65), and limb salvage (77.2% Group OPEN vs 90.4% Group ENDO; P = .17; log-rank, 1.87). Both bypass and endovascular treatment provided safe and effective restoration of patency for femoro-popliteal in-stent occlusion in patients with chronic limb-threatening ischemia. Open surgery was associated with longer stay in hospital and increased use of blood transfusions. At 5 years, no significant differences were found in the rates of overall patency or limb salvage between bypass and endovascular treatment.

Identifiants

pubmed: 37532160
pii: S0741-5214(23)01728-7
doi: 10.1016/j.jvs.2023.07.053
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1270-1277

Investigateurs

Mohammad Abualhin (M)
Marco Andreini (M)
Martina Bastianon (M)
Cristiano Calvagna (C)
Chiara Colacchio (C)
Alessia D'Andrea (A)
Andrea Esposito (A)
Patrizia Dalla Caneva (PD)
Stefano Fazzini (S)
Ciro Ferrer (C)
Enrico Gallitto (E)
Stefano Gennai (S)
Antonio Nicola Giordano (AN)
Nicola Leone (N)
Davide Mastrorilli (D)
Caterina Melani (C)
Jorge Miguel Mena Vera (JM)
Luca Mezzetto (L)
Gianbattista Parlani (G)
Valentina Scarati (V)
Simona Sica (S)
Gioele Simonte (G)
Francesco Squizzato (F)
Paolo Spath (P)
Yamume Thsomba (Y)
Elvira Visciglia (E)
Elisa Zanetti (E)

Informations de copyright

Copyright © 2023 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Mario D'Oria (M)

Division of Vascular and Endovascular Surgery, Cardiovascular Department, University Hospital of Trieste, Trieste, Italy. Electronic address: mario.doria88@outlook.com.

Raffaella Berchiolli (R)

Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Mauro Gargiulo (M)

Department of Vascular Surgery, University of Bologna, Bologna, Italy; Metropolitan Vascular Surgery Unit, IRCCS University Hospital Policlinico S. Orsola, Bologna, Italy.

Michele Antonello (M)

Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.

Giovanni Pratesi (G)

Department of Integrated Surgical and Diagnostic Sciences - DISC, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Stefano Michelagnoli (S)

Vascular and Endovascular Surgery Unit, San Giovanni di Dio Hospital, Florence, Italy.

Roberto Silingardi (R)

Department of Vascular Surgery, University of Modena and Reggio Emilia, Nuovo Ospedale S. Agostino Estense, Modena, Italy.

Giacomo Isernia (G)

Department of Vascular and Endovascular Surgery, University Hospital of Perugia, Perugia, Italy.

Gian Franco Veraldi (GF)

Department of Vascular Surgery, University of Verona School of Medicine, University Hospital of Verona, Verona, Italy.

Giovanni Tinelli (G)

Vascular Surgery Unit Fondazione Policlinico Univeristario A. Gemelli IRCCS, Roma - Università Cattolica del Sacro Cuore Rome, Rome, Italy.

Rocco Giudice (R)

Division of Vascular and Endovascular Surgery, Cardiovascular and Thoracic Department, S. Giovanni-Addolorata Hospital, Rome, Italy.

Arnaldo Ippoliti (A)

Vascular Surgery Unit, Biomedicine and Prevention Department, University of Rome "Tor Vergata", Rome, Italy.

Pierluigi Cappiello (P)

Vascular and Endovascular Surgery Unit, Cardiovascular Department, San Carlo Hospital Potenza, Potenza, Italy.

Massimiliano Martelli (M)

Division of Vascular Surgery, MultiMedica Hospital, Sesto San Giovanni, Italy.

Sandro Lepidi (S)

Division of Vascular and Endovascular Surgery, Cardiovascular Department, University Hospital of Trieste, Trieste, Italy.

Nicola Troisi (N)

Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Classifications MeSH